Skip to main content

Table 4 Clinical outcomes at hospital discharge

From: Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center

 

TNK

(n = 138)

rt-PA

(n = 138)

P Value

mRS score at discharge; median (IQR)

2 (1–3)

3 (2–4)

0.06

Excellent neurological recovery at discharge

(mRS 0–1); n (%)

40 (29%)

28 (20%)

0.09

Good neurological recovery at discharge

(mRS 0–2); n (%)

75 (54%)

59 (43%)

0.05

Excellent neurological recovery at discharge

(mRS 0–1) or back to pre-mRS; n (%)

59 (43%)

51 (37%)

0.33

Favorable neurological recovery at discharge

(mRS 0–2) or back to pre-mRS; n (%)

92 (67%)

79 (57%)

0.11

NIHSS score at discharge, median (IQR)

2 (0–4)

1 (0–5)

0.30

mRS 5–6 at discharge; n (%)

16 (12%)

23 (17%)

0.23

In-hospital mortality; n (%)

7 (5%)

12 (9%)

0.24

Length of hospital stay, d; median (IQR)

5 (3–9)

5 (3–11)

0.33

Discharge destination;n(%)

   

 Death

7 (5%)

12 (9%)

0.26

 Rehabilitation

31 (23%)

36 (26%)

 Nursing home

8 (6%)

9 (7%)

 Home

88 (64%)

72 (52%)

 Other clinic

4 (3%)

9 (7%)

 Stroke mimics; n (%)

12 (9%)

9 (7%)

0.73

  1. Abbreviations: mRS, modified Rankin Scale; IQR, interquartile range; pre-mRS, pre-stroke modified Rankin Score; NIHSS, National Institutes of Health Stroke Scale